1. Inhibition of Huntingtin Exon-1 Aggregation by the Molecular Tweezer CLR01
- Author
-
Simon Ebbinghaus, Christian Heid, Frank-Gerrit Klärner, Anne Steinhof, Kenny Bravo-Rodriguez, Erich E. Wanker, Tobias Vöpel, Abhishek Sharma, Elsa Sanchez-Garcia, Thomas Schrader, Shivang Vachharajani, David Gnutt, Joseph A. Loo, Gal Bitan, Oluwaseun Fatoba, Michael Nshanian, Gisa Ellrichmann, and Sumit Mittal
- Subjects
Bridged-Ring Compounds ,Huntington's Disease ,0301 basic medicine ,Huntingtin ,Chemie ,Molecular Dynamics Simulation ,Neurodegenerative ,Protein aggregation ,Biochemistry ,Article ,Catalysis ,Protein Aggregates ,03 medical and health sciences ,Exon ,Rare Diseases ,Colloid and Surface Chemistry ,Huntingtin Protein ,Humans ,2.1 Biological and endogenous factors ,Aetiology ,Molecular Structure ,Chemistry ,Neurosciences ,Exons ,General Chemistry ,Polyglutamine tract ,Organophosphates ,Brain Disorders ,Cell biology ,Glutamine ,030104 developmental biology ,Chemical Sciences ,Toxicity ,Hydrophobic and Hydrophilic Interactions - Abstract
Huntington's disease is a neurodegenerative disorder associated with the expansion of the polyglutamine tract in the exon-1 domain of the huntingtin protein (htte1). Above a threshold of 37 glutamine residues, htte1 starts to aggregate in a nucleation-dependent manner. A 17-residue N-terminal fragment of htte1 (N17) has been suggested to play a crucial role in modulating the aggregation propensity and toxicity of htte1. Here, we identify N17 as a potential target for novel therapeutic intervention using the molecular tweezer CLR01. A combination of biochemical experiments and computer simulations shows that binding of CLR01 induces structural rearrangements within the htte1 monomer and inhibits htte1 aggregation, underpinning the key role of N17 in modulating htte1 toxicity.
- Published
- 2017
- Full Text
- View/download PDF